Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Envoy Medical ( (COCH) ) has issued an update.
On November 19, 2025, Envoy Medical, Inc. received a notice from Nasdaq indicating that its Class A Common Stock failed to meet the $1.00 minimum bid price requirement for continued listing. The company has until May 18, 2026, to regain compliance, with options including a reverse stock split if necessary. Failure to comply may result in delisting, though the company plans to monitor stock prices and consider actions to meet the requirements.
The most recent analyst rating on (COCH) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on Envoy Medical stock, see the COCH Stock Forecast page.
Spark’s Take on COCH Stock
According to Spark, TipRanks’ AI Analyst, COCH is a Neutral.
The overall stock score is heavily impacted by the company’s poor financial performance, which is the most significant factor. Technical analysis also indicates bearish momentum, further contributing to the low score. Valuation metrics are unfavorable due to negative earnings and lack of dividends.
To see Spark’s full report on COCH stock, click here.
More about Envoy Medical
Envoy Medical, Inc. operates in the medical industry, focusing on innovative hearing solutions and technologies.
Average Trading Volume: 2,902,368
Technical Sentiment Signal: Sell
Current Market Cap: $22.13M
See more data about COCH stock on TipRanks’ Stock Analysis page.